Close

Evoke Pharma (EVOK) Gains Following Positive Study of Metoclopramide Nasal Spray

January 22, 2014 9:10 AM EST Send to a Friend
Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the publication ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login